Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$651M |
| 2 |
Monster Beverage
MNST
|
+$615M |
| 3 |
Intercontinental Exchange
ICE
|
+$556M |
| 4 |
Johnson & Johnson
JNJ
|
+$382M |
| 5 |
Applied Materials
AMAT
|
+$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$771M |
| 3 |
Deere & Co
DE
|
+$597M |
| 4 |
Meta Platforms (Facebook)
META
|
+$543M |
| 5 |
Microsoft
MSFT
|
+$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Disc Medicine
IRON
$2.1B
| $36.8M | 0.02% |
749,827
+303,954
| +68% | +$14.9M |
|
452
United Parcel Service
UPS
$71.5B
| $36.7M | 0.02% |
269,498
+180,519
| +203% | +$24.6M |
|
453
IQVIA
IQV
$32.2B
| $36.4M | 0.02% |
153,560
-3,993
| -3% | -$946K |
|
454
Larimar Therapeutics
LRMR
$331M
| $36.4M | 0.02% |
5,566,855
+1,189,467
| +27% | +$7.77M |
|
455
OneMain Financial
OMF
$7.23B
| $36.4M | 0.02% |
772,864
+315,640
| +69% | +$14.9M |
|
456
Perimeter Solutions
PRM
$3.25B
| $36.3M | 0.02% |
2,698,180
-1,653
| -0.1% | -$22.2K |
|
457
Cardinal Health
CAH
$36B
| $36.2M | 0.02% |
327,456
-63,942
| -16% | -$7.07M |
|
458
Bath & Body Works
BBWI
$5.82B
| $35.8M | 0.02% |
1,121,520
+559,851
| +100% | +$17.9M |
|
459
TriNet
TNET
$3.32B
| $35.6M | 0.02% |
367,475
-34,069
| -8% | -$3.3M |
|
460
PotlatchDeltic
PCH
$3.22B
| $35.1M | 0.02% |
778,559
-166,599
| -18% | -$7.51M |
|
461
Rocket Pharmaceuticals
RCKT
$346M
| $35.1M | 0.02% |
1,897,340
-1,021,738
| -35% | -$18.9M |
|
462
Paychex
PAYX
$48.3B
| $35M | 0.02% |
260,590
+200,640
| +335% | +$26.9M |
|
463
Martin Marietta Materials
MLM
$37B
| $34.7M | 0.02% |
64,518
| – | – |
|
464
CRA International
CRAI
$1.3B
| $34.7M | 0.02% |
197,922
+8,155
| +4% | +$1.43M |
|
465
SPDR Gold Trust
GLD
$115B
| $34.3M | 0.02% |
141,263
+2,464
| +2% | +$599K |
|
466
Lexeo Therapeutics
LXEO
$280M
| $34M | 0.02% |
3,763,195
+599,203
| +19% | +$5.41M |
|
467
4D Molecular Therapeutics
FDMT
$326M
| $33.9M | 0.02% |
3,137,087
-59,675
| -2% | -$645K |
|
468
Eagle Materials
EXP
$7.42B
| $33.9M | 0.02% |
117,819
-61,379
| -34% | -$17.7M |
|
469
CMS Energy
CMS
$21.2B
| $33.8M | 0.02% |
479,203
+440,000
| +1,122% | +$31.1M |
|
470
Air Products & Chemicals
APD
$63.9B
| $33.5M | 0.02% |
112,511
-68,722
| -38% | -$20.5M |
|
471
Piper Sandler
PIPR
$5.91B
| $33.5M | 0.02% |
117,933
-156,839
| -57% | -$44.5M |
|
472
OmniAb
OABI
$226M
| $33.3M | 0.02% |
7,871,328
+3,104
| +0% | +$13.1K |
|
473
FB Financial Corp
FBK
$2.85B
| $33.2M | 0.02% |
706,637
-423,322
| -37% | -$19.9M |
|
474
Napco Security Technologies
NSSC
$1.43B
| $33M | 0.02% |
816,264
-96,990
| -11% | -$3.92M |
|
475
Spyre Therapeutics
SYRE
$1.01B
| $32.9M | 0.02% |
1,120,531
+446,664
| +66% | +$13.1M |
|